129 results on '"Pai, Amy Barton"'
Search Results
2. Approaches to Medication Management in Patients with Kidney Failure Opting for Conservative Management
3. In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations
4. Lipoteichoic acid as a Potential Noninvasive Marker of Biofilm in Dialysis Access
5. Lipoteichoic Acid as a Potential Noninvasive Biomarker of Biofilm in Dialysis Access
6. Drug Transporter Function—Implications in CKD
7. Risky Business: Lessons from Medication Misadventures in Chronic Kidney Disease
8. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation
9. Medication-related Problems in CKD
10. Evaluating Plasma Pharmacokinetics of Intravenous Iron Formulations: Judging Books by Their Covers?
11. Controversies in Optimal Anemia Management : Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
12. Using the MedLit-D tool to assess medication label literacy in patients on hemodialysis.: 139.
13. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose
14. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose
15. Medication management services for dialysis patients in Brazil.: 340.
16. Oxidative Stress and Inflammation in Chronic Kidney Disease: Role of Intravenous Iron and Vitamin D
17. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: A prospective, open-label study
18. Prevalence of Chronic Kidney Disease in Patients Undergoing Cardiac Rhythm Device Removal
19. 144E. Effects of the ESRD medicare bundling rule on anemia management in private dialysis units.
20. Reduced Drug Use and Hospitalization Rates in Patients Undergoing Hemodialysis Who Received Pharmaceutical Care: A 2-Year, Randomized, Controlled Study
21. Estimation of creatinine clearance in morbidly obese patients
22. Correlation between the renal quality of life profile and short form-36 in a United States hemodialysis population
23. Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: A 2-year randomized, controlled study
24. Elevated serum creatinine levels associated with fenofibrate therapy
25. Comparison of Oxidative Stress Markers After Intravenous Administration of Iron Dextran, Sodium Ferric Gluconate, and Iron Sucrose in Patients Undergoing Hemodialysis
26. Sampling for International Normalized Ratios in Patients on Hemodialysis with Central Venous Catheters
27. Frequency of hyperkalemia in hemodialysis patients on angiotensin-converting enzyme inhibitor (ACE-I) and angiotensin receptor blocker (ARB) therapy.: 218.
28. Vancomycin dosing in high flux hemodialysis: A limited-sampling algorithm
29. Broader roles of vitamin D in patients with chronic kidney disease
30. Nephrology practice and research network opinion paper: Pharmacists' perspectives on the Advancing American Kidney Health initiative.
31. Impact of hemodialysis on the concentrations of sodium and potassium during infusion of sodium thiosulfate using an In Vitro hemodialysis model.
32. Patient-selected media and knowledge of risk to kidneys of nonsteroidal anti-inflammatory drugs.
33. Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury.
34. Endotoxin Binding by Sevelamer: Potential Impact on Nutritional Status
35. NSAID-Avoidance Education in Community Pharmacies for Patients at High Risk for Acute Kidney Injury, Upstate New York, 2011.
36. Keeping kidneys safe: The pharmacist's role in NSAID avoidance in high-risk patients.
37. Lipoteichoic Acid from Staphylococcus aureus Induces Lung Endothelial Cell Barrier Dysfunction: Role of Reactive Oxygen and Nitrogen Species.
38. Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
39. Use of Antibiotic Lock Solutions in Hemodialysis Catheter-Related Bloodstream Infections.
40. Intravenous Iron and Oxidative Stress.
41. CKD: Pharmacotherapy in a House of Mirrors
42. It is all About “ADME”
43. Assessment of literacy and numeracy skills related to medication labels in patients on chronic in-center hemodialysis.
44. Intravenous Iron and Bacteremia in Hemodialysis Patients.
45. Warfarin for Prevention of Vascular Access Thrombosis in Hemodialysis Patients.
46. Assessment of literacy and numeracy skills related to non-steroidal anti-inflammatory drug labels.
47. NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011.
48. Preparing for implementation of a medication reconciliation measure for dialysis: Expanding the role of pharmacy technicians.
49. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?
50. Association between NSAID Exposure and Kidney Function Decline in Primary Care Patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.